I agree that this site is using cookies. You can find further informations here.
X
Bosch, Bronwyn
41  results:
Search for persons X
?
1

Final 192-Week Efficacy and Safety Results of the ADVANCE T..:

Sokhela, Simiso ; Venter, Willem D F ; Bosch, Bronwyn...
Open Forum Infectious Diseases.  11 (2024)  3 - p. , 2024
Link: https://doi.org/10.1093/..
 
?
2

Risks of metabolic syndrome in the ADVANCE and NAMSAL trial:

Tovar Sanchez, Tamara ; Mpoudi-Etame, Mireille ; Kouanfack, Charles...
Frontiers in Reproductive Health.  5 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
3

Comparing Prospective Incident Severe Acute Respiratory Syn..:

Sokhela, Simiso ; Bosch, Bronwyn ; Hill, Andrew...
Open Forum Infectious Diseases.  9 (2022)  12 - p. , 2022
Link: https://doi.org/10.1093/..
 
?
4

Randomized clinical trial of nitazoxanide or sofosbuvir/dac..:

Sokhela, Simiso ; Bosch, Bronwyn ; Hill, Andrew...
Journal of Antimicrobial Chemotherapy.  77 (2022)  10 - p. 2706-2712 , 2022
Link: https://doi.org/10.1093/..
 
?
5

Weight and Metabolic Changes After Switching From Tenofovir..:

Bosch, Bronwyn ; Akpomiemie, Godspower ; Chandiwana, Nomathemba...
Clinical Infectious Diseases.  76 (2022)  8 - p. 1492-1495 , 2022
Link: https://doi.org/10.1093/..
 
?
6

Weight gain stopping/switch rules for antiretroviral clinic..:

Venter, W.D. Francois ; Sokhela, Simiso ; Calmy, Alexandra...
AIDS.  35 (2021)  Supplement 2 - p. S183-S188 , 2021
Link: https://doi.org/10.1097/..
 
?
7

Participants on Dolutegravir Resuppress Human Immunodeficie..:

Pepperrell, Toby ; Venter, Willem Daniel Francois ; McCann, Kaitlyn...
Clinical Infectious Diseases.  73 (2021)  4 - p. e1008-e1010 , 2021
Link: https://doi.org/10.1093/..
 
?
8

Risks of metabolic syndrome in the ADVANCE and NAMSAL trial:

Tovar Sanchez, Tamara ; Mpoudi-Etame, Mireille ; Kouanfack, Charles...
http://eprints.lse.ac.uk/120539/1/frph_05_1133556.pdf.  , 2023
Link: http://eprints.lse.ac.uk..
 
?
9

Risks of metabolic syndrome in the ADVANCE and NAMSAL trial:

Tovar Sanchez, Tamara ; Mpoudi-Etame, Mireille ; Kouanfack, Charles...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10544962/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
10

Comparing Prospective Incident Severe Acute Respiratory Syn..:

Sokhela, Simiso ; Bosch, Bronwyn ; Hill, Andrew...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9757672/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
11

Randomized clinical trial of nitazoxanide or sofosbuvir/dac..:

Sokhela, Simiso ; Bosch, Bronwyn ; Hill, Andrew...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9384711/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
12

Randomized clinical trial of nitazoxanide or sofosbuvir/dac..:

Sokhela, Simiso ; Bosch, Bronwyn ; Hill, Andrew...
http://eprints.lse.ac.uk/117167/1/dkac266.pdf.  , 2022
Link: http://eprints.lse.ac.uk..
 
?
13

Weight gain stopping/switch rules for antiretroviral clinic..:

Venter, W D Francois ; Sokhela, Simiso ; Calmy, Alexandra...
info:eu-repo/semantics/altIdentifier/doi/10.1097/QAD.0000000000003092.  , 2021
Link: https://archive-ouverte...
 
?
14

Weight gain stopping/switch rules for antiretroviral clinic..:

VENTER, WD Francois ; SOKHELA, Simiso ; CALMY, Alexandra...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8694575/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
15

Weight gain stopping/switch rules for antiretroviral clinic..:

Venter, W.D. Francois ; Sokhela, Simiso ; Calmy, Alexandra...
info:eu-repo/semantics/altIdentifier/doi/10.1097/QAD.0000000000003092.  , 2021
Link: https://hal.umontpellier..
 
1-15